Upcoming Webinars
-
Ripped from the Headlines: Hot Topics in Life Sciences 2026
The life sciences industry is constantly changing, and equally dynamic are the challenges industry participants encounter. Join Medmarc's Risk Managers to discuss these changes from 2026.
Register for Ripped from the Headlines: Hot Topics in Life Sciences 2026 Read More about Ripped from the Headlines: Hot Topics in Life Sciences 2026 -
Claims 2026: Navigating an Increasingly Difficult World for Life Sciences
Join Andy Hall as he gives an update on the claims and legal environment for life science companies.
Register for Claims 2026: Navigating an Increasingly Difficult World for Life Sciences Read More about Claims 2026: Navigating an Increasingly Difficult World for Life Sciences
Past Webinars
-
Ripped from the Headlines: Hot Topics in Life Sciences
The life sciences industry is constantly changing, and equally dynamic are the challenges industry participants encounter.
Read More about Ripped from the Headlines: Hot Topics in Life Sciences -
Importing Medical Devices into the U.S. in Compliance with the U.S. FDA
This webinar will provide a basic overview of FDA regulations and requirements to import medical devices into the U.S. Jennifer Diaz will discuss how the FDA defines and regulates a medical device and the pathway to legally market a medical device in the U.S.
Read More about Importing Medical Devices into the U.S. in Compliance with the U.S. FDA -
Managing Risks through IP Innovation Management Training
A recent survey of 1,500 global innovation executives revealed that innovation management continues to be a top priority. IP Innovation Management Standard 56005 is a global framework that can help companies consistently identify, manage, and mitigate their on-going risks and opportunities related to intellectual property.
Read More about Managing Risks through IP Innovation Management Training -
The mRNA/Lipid Nanoparticle Competitive and Litigation Landscape
While the COVID-19 pandemic caused tragedy for millions of families worldwide, it has also spurred concomitant advancements in health care, not the least of which include the first-ever regulatory approvals of therapies based on messenger RNA (mRNA) technology granted to Moderna and BioNTech (in collaboration with Pfizer).
Read More about The mRNA/Lipid Nanoparticle Competitive and Litigation Landscape